Sign in
4

Changes in Ownership

NEKTAR THERAPEUTICS Filed Acc 0001209191-23-050330

Options or other derivatives

  • Director acquired 85,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
GREER R SCOTT Director 2023-09-19 Grant or award · Stock Option +85,000 85,000 D: show line 1 in the form
Loading xslF345X05/doc4.xml…